Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Igor Puzanov

51-60 of 60 results

Final planned overall survival (OS) from OPTiM, a randomized Phase III trial of talimogene laherparepvec (T-VEC) versus GM-CSF for the treatment of unresected stage IIIB/C/IV melanoma (NCT00769704)

article

Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies

scientific article published on August 1, 2015

Phase 1 results of a phase 1b/2, multicenter, open-label trial to evaluate safety and efficacy of talimogene laherparepvec (T-VEC) and ipilimumab (ipi) vs ipi alone in previously untreated, unresected stage IIIB-IV melanoma.

scientific article published on 7 November 2013

Development of chronic lymphocytic leukaemia during ipilimumab therapy in a patient with metastatic melanoma.

scientific article published on 14 August 2015

Ontogeny and differentiation of murine natural killer cells and their receptors

scientific article published on 01 January 1998

Thyroid nodule: not as clear-cut as it seems

scientific article published on 01 January 2016

Association between durable response (DR) and overall survival (OS) in patients with unresected stage IIIb-IV melanoma treated with Talimogene Laherparepvec (T-VEC) in the Phase III OPTiM trial.

scientific article published on 6 November 2014

BRAF mutation: a novel approach in targeted melanoma therapy

scientific article

Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7).

scientific article published on 6 May 2014

Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma.

scientific article published on 6 May 2014